Proniras
Facts
- HQ
- Seattle, WA, US
- Sectors
- Biotech
- Founded
- 2018 Seattle business license
- Type
- Corporation Seattle business license
- Registered name
- Proniras Corporation Seattle business license
- Members see funding amounts. .
Is this your organization? Claim it
Proniras launches in Seattle to develop Eli Lilly’s tezampanel, wins $89.5M BARDA contract
Proniras Corporation launched in Seattle to develop tezampanel, a seizure drug originally created by Eli Lilly, and secured an $89.5 million BARDA contract contingent on development milestones. The company also received undisclosed launch funding from several investors, will be led by co-founder and CSO Chris Toombs, and plans to explore tezampanel as both a seizure therapy and a nerve-agent antidote.